SCHEMBL30748192

SCHEMBL30748192

NCc1ccn(S(=O)(=O)c2cccnc2)c1-c1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
GAA P10253 2/20 0.37
KMT2A Q03164 1/20 0.37
HTR6 P50406 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR1F P30939 1/20 0.36
HTR7 P34969 1/20 0.36
DRD3 P35462 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.35
NAPRT Q6XQN6 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29141633 1.00 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4GAA
SCHEMBL29601431 0.87 CHRNB2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4GAA
SCHEMBL30267526 0.82 CHRNB2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4HTR6
SCHEMBL28649101 0.82 CHRNB2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4HTR6
SCHEMBL28558398 0.81 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4GAA
SCHEMBL29538386 0.81 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4GAA
Fumaric Acid SCHEMBL30911879 0.79 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4GAA
SCHEMBL29601544 0.77 CHRNB2 (0.39) CHRNB2CHRNB4CHRNA3CHRNA4GAA
SCHEMBL28054466 0.77 CHRNB2 (0.39) CHRNB2CHRNB4CHRNA3CHRNA4GAA
SCHEMBL29141637 0.77 TP53 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448907-B Compound for treating peptic ulcer, intermediate and preparation method thereof 赛隆药业集团股份有限公司 2024-01-12 CN disclosed